Drugs / DC cells
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT03815084 | Feb 2019 → Feb 2020 | neoplasm | Allife Medical Science and Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase 0 | NCT03815630 | Feb 2019 → Feb 2020 | neoplasm | Allife Medical Science and Technology Co., Ltd. | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT06015269 | Aug 2023 → Jul 2025 | cancer | Shanghai Cell Therapy Group Co.,Ltd | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01947569 | Oct 2013 → Nov 2014 | type 1 diabetes mellitus | DiaVacs, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC cells | “60million DC cells and 1.5 billion CIK at day1” NCT03815630 ↗3“60million DC cells and 3 billion NK at day1” NCT03815084 ↗ “DC cells which have not been modified.” NCT01947569 ↗ |
| Modality | Cell therapy | “DC cells which have not been modified.” NCT01947569 ↗ |